Proteotype Diagnostics Ltd
12273695
Healthy
- No accounts filed in last 18 months (-5)
Details
Compliance
Last accounts
31/10/2024
total exemption full
Next accounts due
31/07/2026
Confirmation statement
Last: 31/05/2025
Due 14/06/2026
Industry
Officers
Persons with Significant Control
Mr Wesley Timothy Sukdao
South African · England · Age 39
Babraham Research Campus, Babraham, Cambridge, CB22 3AT
Notified 21/10/2019
Dr Emma Victoria Yates
British,American · England · Age 37
Babraham Research Campus, Babraham, Cambridge, CB22 3AT
Notified 21/10/2019
CompanyRankvs 415+ SIC 72110 peers75
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/10/2024
Net Worth
£150k
Balance sheet strength
Cash
£86k
Cash in the bank
Net Current Assets
£453k
Working capital
Current Assets
£469k
Current Liabilities
£16k
Fixed Assets
£94k
Debtors
£383k
Tax at Year End
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 28.73 | -£156k |
| 2023 | 5.14 | +£264k |
| 2022 | Infinity | +£9k |
| 2021 | Infinity | — |
| 2020 | Infinity | — |
Derived from filed accounts. Not audited figures.